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ABSTRACT 
In development of new product major constraints are poor aqueous solubility and low oral bioavailability. Crystallization is one the 
approach has been used for enhancement of solubility of poorly aqueous soluble drugs also helps to improve physicochemical properties 
such as melting point, tabletability, solubility, stability, bioavailability and permeability with preserving the pharmacological properties of 
the active pharmaceutical ingredient. Different methods have been used for the synthesis of cocrystal such as grinding, slurry, antisolvent, 
hot melt extrusion, sonocrystallization, supercritical fluid, spray drying etc. The article highlights the co-crystallization, its methods and 
significance. 
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INTRODUCTION 
From recently discovered large numbers of drugs around 
60-70% are related to the BCS Class II (low solubility/high 
permeability) and IV (low solubility/ low permeability)1 
and cause difficulty related to dissolution, solubility, 
stability, therapeutic efficacy etc.2. Need of today’s era is to 
decrease problems regarding solubility and permeability of 
available drugs with different methods. Multi-component 
crystals like solvates, hydrates, co-crystals, salts contribute 
key role in the design of new solids mainly in the 
pharmaceutical area.  
Cocrystals:  
Crystallization is defined as alteration of physical 
properties of by modifying drug at molecular level. Process 
of Cocrystallization requires drug and coformer for 
formation of cocrystal. 
Cocrystals are multicomponent molecular crystals where 
all components are at a stoichiometric ratio and comprise 
of two or more chemically different molecules includes 
modification of drugs to alter physical properties of a drug, 
especially a drug’s solubility without altering its 
pharmacology effect. 3,4,5 
Implications of cocrystals: 
Cocrystallization is defined as alteration of physical 
properties of by modifying drug at molecular level means 
one can tailored physicochemical properties of drugs to 
improve it by mans of various methods enlisted blow, so 
there is no need to any other additives to improve 
physicochemical property of substances11. APIs and 
conformers properties, nature of molecular interaction 
between them and synthetic procedures are important 
factors in altering only physicochemical properties but not 
alter pharmacological properties. The effect on the 
physicochemical properties of the API is dependent on the 
available coformer12,13.  
Pharmaceutical cocrystals can enhance the 
physicochemical properties of drugs like melting point, 
tabletability, solubility, stability, bioavailability, 
permeability and these properties are highlighted here 
with suitable examples. 
Melting point:  
It is one of the physical properties of solid and used for 
determination of purity. Pure substances or solid melt at 
sharp meting point with narrow range15. Thermodynamic 
stability of any API can be govern by its meting point so 
utility of high melting point conformer for its better 
stability and also useful in case of thermolabile drugs, so 
selection of conformer is very important in case of 
synthesis of cocrystals16. Differential scanning calorimetry 
(DSC) and thermal gravimetric analysis (TGA) are most 
common techniques used to determine melting point. 
Zhang et al studied synthesis of Carbamazepine Cocrystal 
by using Nicotinamide and saccharin as conformer in two 
different solvents like ethanol-water solvent mixture and 
polyvinyl pyrrolidone (PVP) solution. Author studied 
melting point of cocrystal with the help of differential 
scanning colorimetry and observed that in case of DSC 
curve of starting material that is carbamazepin and 
nicotinamide  in ethanol water mixture showed melting 
around 195°C and 132°C, respectively. And cocrystals 
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formed showed single endothermal peak is around 162°C, 
which was located between the melting point of 
carbamazepin and nicotinamide, while carbamazepine and 
saccharin in ethanol water mixture showed melting around 
176 and 181°C and cocrystals formed showed melting 
point at 173°C17. Jadhav et al  (also studied melting point 
study of fenofibrate cocrystals formed with different 
conformers like para amino benzoic acid, benzoic acid and 
salicylic acid and observed that melting point of pure 
fenofibrate was at 78-82ºC and melting points of 
conformers like para amino benzoic acid, benzoic acid and 
salicylic acid was 184-186°C, 158-160°C, 122-124°C 
respectively, while conformers formed showed melting 
point at 76-78°C, 74-76°C, 70-72°C respectively. Author 
concluded that melting point of fenofibrate was decreased 
than pure one and individual conformers18. Author 
synthesized Cocrystal of Piroxicam using sodium acetate, 
saccharine sodium Urea, Nicotinamide, resorcinolas 
conformer and studied difference in melting point of drug 
and cocrystals. Melting point of sodium acetate, saccharine 
sodium coformers were high previously but after forming 
cocrystal with Piroxicam it get decreased, while melting 
point of cocrystal of Urea, Nicotinamide, resorcinol was 
increased19.  
 
 
 
 
 
 
 
 
Tabletability:  
Tabletability means ability of substance to get covert in 
tablet form. Crystal packing, tabletability and compaction 
are important parameters of preformulation study; with 
help of cocrystallization we can alter these properties by 
using suitable conformers. Zheng zheng et al synthesized 
cocrystals of Resveratrol with conformers 4-
aminobenzamide and isoniazid and studied its enhanced 
solubility and tabletability. Author observed that 
tabletability of RES is poor and because of this even at high 
pressure that is 0.6 MPa and lamination of tablets, while 
tablets prepared with cocrystals of Resveratrol-4-
aminobenzamide, tensile strength more than 3 MPa is 
attained at 250 MPa compaction pressure. Author 
concluded that cocrystal formation improved tabletability 
of drug. Compaction behavior of cocrystals of paracetamol 
with trimethylglycine and oxalic acid was found to be 
better than pure drug. Tabletability of resveratrol was 
enhanced by formation of cocrystals with 4-
aminobenzamide and isoniazid. Cocrystals showed higher 
tabletability than either pure drug or coformers. 
Mechanical properties of APIs could be altered by varying 
crystal packing by cocrystallization and cocrystals of 
vanillin isomers with same coformer showed higher 
tabletability than isomers and coformer20. Paracetamol 
have poor compression property, to overcome this 
problem normally we use wet granulation method for 
preparation of paracetamol tablet and this is very tedious 
job, so to resolve this problem Latif et al. synthesized 
paracetamol cocrystals to improve compaction or 
tabletability of paracetamol. Author prepared cocrystal of 
paracetamol by using caffine as conformer by methods like 
dry grinding; liquid assisted grinding, solvent evaporation, 
anti-solvent addition and observed that the compaction 
power and mechanical property of paracetamol has been 
increased21. 
Solubility:  
As discussed in introduction about 60 to 70 % drugs are 
belongs to BCS Class II (low solubility/high permeability) 
and IV (low solubility/ low permeability)1, so its need to 
improve solubility of these drugs to develop the various 
formulations. With development of cocrystal one can 
increase the solubility of lo soluble drug many researchers 
have been improved solubility of drug with this technique.  
For eg. Mounika et al. developed cocrystals of Fexofenadine 
by using Tartaric acid as conformer by solvent evaporation 
technique and studied cocrystals for saturation solubility 
according to the method of Higuchi and Connors. Author 
performed drug solubility study with water as well as 0.01 
N HCl and observed that solubility of Co-crystals in water is 
increase with 11 folds more than the pure drug and 
solubility of Co-crystals in 0.01 N HCL is 2.47 folds more 
than the pure drug22. Iyan et al developed Simvastatin-
nicotinamide co-crystals by solvent evaporation to 
improve the solubility of simvastatin by co-crystallization 
using nicotinamide as co-crystal agent or co-former and 
evaluated for solubility. Observation was saturated 
solubility of co-crystal show a threefold increase compared 
to raw simvastatin23. Chadha et al also improved solubility 
of efavirenz by cocrystal technique. Author synthesized 
cocrystals of efavirenz by using oxalic acid dihydrate and 
citric acid monohydrateas conformers to improve a 
physicochemical property that is solubility and dissolution 
rate. As both conformers have high water solubility that is 
14.3g/100 ml and 64.7g/100 ml respectively and contain 
hydrogen bond donor and acceptor groups, which can be 
used for designing cocrystals of efavirenz leading to 
improvement in solubility24. Shubhangi et al synthesized 
cocrystals of poorly water soluble drug Darunavir. It is BCS 
Class II drug having low solubility. Co crystals were 
developed by cooling crystallization method using succinic 
acid as conformer. Author determined aqueous solubility 
of darunavir by saturation solubility by dissolving excess 
amount of cocrystals in water for 24 hrs on the rotary 
shaker, analyzed with spectrophotometer and observed 
that with Cocrystallization technique there is significant 
improvement in the aqueous solubility, found 1.92 fold 
increases in saturation solubility25. Author Rajurkar   also 
developed Co Crystals of Ezogabine to improve Aqueous 
Solubility using carboxylic acids as conformer by grinding; 
ultrasound assisted co-crystallization and solvent 
evaporation techniques and found that 10-11 fold 
improvement in solubility of co crystals than pure drug26. 
Muddukrishna et al studied synthesis of paclitaxel and 
naringen cocrystal to improve solubility by solvent 
assisted grinding method.  Paclitaxel (PTX) is a class-4 
drug; this drug has low aqueous solubility.  Solubility study 
Physicochemical properties can 
alter with cocrystal techniques 
Melting 
point 
 
Bioavailability 
 
Stability 
 
Solubility 
 
Tabletability 
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of paclitaxel and naringen cocrystal was done at room 
temperature for 72 hours by shake flask method, analyzed 
samples with HPLC method and found 2.4 fold increases in 
the saturation solubility27. Prabhakar et al also prepared 
Cocrystal of Piroxicam and studied for solubility. Author 
used various conformers like adipic acid , benzoic acid, 
cinnamic acid, citric acid, glutaric acid, phydroxybenzoic 
acid, hippuric acid, malonic acid, resorcinol, saccharine 
sodium, 1-hydroxy-2- napthoic acid, sodium acetate, urea, 
catechol, ferulic acid, aerosil-200, nicotinamide, para 
amino benzoic acid, anthranilic acid and succinic acid for 
synthesis of cocrystals and performed saturated aqueous 
solubility of cocrystal and found significant increase in 
solubility of drug after formulating as cocrystals [28]. 
Muddukrishna Co-Crystals of Etraverine to improve 
Solubility by using Tartaric Acid as conformer with slow 
evaporation technique. Etravirine is a BCS Class IV drug 
having lo solubility and low permeability. Solubility study 
of cocrystals was done by shake flask method and found 
3.6 fold increase in solubility of cocrystals than pure 
drug29. 
Stability:  
It is also imperative study has to be done during the 
development of new dosage formulation. Different stability 
studied like chemical stability, thermal stability, solution 
stability and photostability should be performed during 
development of pharmaceutical cocrystals. Iyan 23 et al 
developed Simvastatin-nicotinamide co-crystals by solvent 
evaporation to improve the solubility of simvastatin by co-
crystallization using nicotinamide as co-crystal agent or co-
former and evaluated for stability study at 40oC and 
relative humidity (RH) 75% in one month found it stable. 
Bioavailability:  
Bioavailability is defined as the rate and extent of pure 
drug that reaches into systemic circulation. Low oral 
bioavailability of APIs is one of the major challenges in 
development of formulations, with help of cocrystallization 
one can enhance or improve the bioavailability of drug. 
Many researchers has been enhanced the bioavailability of 
different drugs with conversion in cocrystal form. For eg. 
Mounika et al prepared cocrystals of Fexofenadine. 
Fexofenadine is class II drug according to the BCS 
classification with low solubility and high permeability, the 
rate limiting steps in attaining desired bioavailability. 
Hence Author prepared cocrystals of Fexofenadine using 
Tartaricacid as a co-former by solvent evaporation and 
observed that with cocrystallisation technique drug hoed 
maximum release as compared to the formulation22. Pinky 
et al formulated cocrystals tablets dosage form of 
clarithromycin to enhance the bioavailability. As 
Clarithromycin is BCS Class II drug author prepared 
cocrystals by using urea as conformer by solvent 
evaporation method. Developed tablet formulation and 
evaluated. Author concluded that the formulated tablets of 
Clarithromycin co-crystals showed improved solubility and 
in-vitro drug release profile as compared to Marketed 
Tablet. And thereby increases oral bioavailability and 
therapeutic effect35. Zhang et al studied synthesis of 
Carbamazepine Cocrystal by using Nicotinamide and 
saccharin as conformer by solvent evaporation 
technique36. 
Methods of Preparation: 
Co-crystal formation described in the literature indicates 
the notoriously difficult situation these systems present 
with regard to preparation it has been known to take 6 
months to prepare a single co-crystal of suitable quality for 
single X-ray diffraction analysis. This is partly because such 
a heteromeric system will only form if the non-covalent 
forces between two (or more) molecules are stronger than 
between the molecules in the corresponding homomeric 
crystals. Design strategies for co-crystal formation are still 
being researched and the mechanism of formation is far 
from being understood. 
Co-crystals can be prepared by solvent and solid based 
methods. The solvent-based methods involve slurry 
conversion solvent evaporation, cooling crystallization and 
precipitation. The solid based methods involve net 
grinding; solvent-assisted grinding and sonication (applied 
to either to wet or dry solid mixtures) 80 to 85° C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Methods of preparation of cocrystals 
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Grinding: 
 
 
 
 
 
 
 
Figure 2: Grinding techniques for preparation of cocrystals 
 
1. Dry Grinding: (Pharmaceutical Cocrystals: An 
Overview) 
Drug + Coformer 
(In a stoichiometric ratio) 
Grind 
(Mortar and pestle or ball mill) 
 
2. Wet Grinding:  
Drug + Coformer 
(In a stoichiometric ratio) 
 
Grind 
(Mortar and pestle or ball mill) 
 
Cocrystals have been synthesized by grinding method 
Sungyup et al prepared Adefovir dipivoxil Co-crystals by 
using glutaric acid and suberic acid as conformer by liquid-
assisted grinding37, Prabhakar et al synthesized Cocrystal 
of Piroxicam by dry grinding method, sodium acetate used 
as conformer. Author reported modified properties of 
piroxicam cocrystal and formulated orodispersible tablets 
having faster disintegration and greater dissolution rate. 
Ibuprofen-amino acids co-crystal screening via co-grinding 
methods 28. Muhamad et al synthesized Ibuprofen-amino 
acids cocrystals by dry grinding as well as liquid assisted 
grinding method38. Gaikwad et al studied synthesis of 
cocrystals of Fenofibrate by grinding method39. 
Slurry conversion:  
Drug + Coformer 
(In a stoichiometric ratio) 
 
Addition of solvent to form slurry 
Slurry conversion experiments were conducted in different 
organic solvents and water. Solvent (100 or 200 ml) was 
added to the co-crystal (20 mg) and the resulting 
suspension was stirred at room temperature for some 
days. After some days, the solvent was decanted and the 
solid material was dried under a flow of nitrogen for 5 min. 
The remaining solids were then characterized using PXRD. 
For eg DWI et al reported synthesis of nicotinamide 
cocrystal by slurry method.  Author mixed both powders of 
Artesunate and nicotinamide homogeneously in mortar 
and added water to the mixture to form slurry40. Noriyuki 
et al studied synthesis of corystals of stanolone and 
mestanolone using slurry crystallization41. Prafulla et al 
synthesized caffeine/maleic acid co-crystal by ultrasound-
assisted slurry co-crystallization techniques42. Erizal et al 
prepared cocrystals of trimethoprim and sulfamethoxazole 
by slurry technique. Cocrystallization was formed 
by simply adding   water  as  solvent  to  mixture  of  
trimethoprim and sulfamethoxazole and developed 
cocrystals was characterized  by  thermomicroscopy, 
scanning  electron  microscope,  powder  X-ray  diffraction,  
differential  scanning  calorimetry. Author also studied 
effect of temperature on formation of cocrystal and 
observed that transformation to cocrystalline phase was 
accelerated by increasing the temperature of storage 43. 
Antisolvent addition: 
This is one of the methods for precipitation or 
recrystalization of the co-crystal former and active 
pharmaceutical ingredient. Solvents include buffers (pH) 
and organic solvents. For example preparation of co-
crystals of aceclofenac using chitosan, in which chitosan 
solution was prepared by soaking chitosan in glacial acetic 
acid. A weighed amount of the drug was dispersed in 
chitosan solution by using high dispersion homogenizer. 
This dispersion was added to distilled water or sodium 
citrate solution to precipitate chitosan on drug. Momoko et 
al studied synthesis of co-crystals by Antisolvent addition 
method by two sequences44. 
 
 
First sequence was: 
Carbamazepin rich polysaturated solution feeded in crystallizer 
Saccharin rich polysaturated solution 
Water was added into the solution 
Particles were sampled after addition of both the solvents 
Grinding techniques 
Dry Grinding Wet Grinding 
Addition of some drops of 
solvent in mixture 
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Second sequence was:  
Carbamazepin rich polysaturated solution feeded in crystallizer 
 
Water was added into the solution 
 
Saccharin rich polysaturated solution 
 
Particles were sampled after addition of both the solvents 
 
And characterized sample by X-ray diffraction (XRD) 
analysis. While Jeong et al and Nan-Hee et al prepared 
indomethacin–saccharin co-crystals by an anti-solvent 
crystallization process and compared with co-crystals by 
evaporation method45,46.  
Hot melt extrusion  
 
Drug + Coformer 
 
Form co-crystal 
 
Hot melt extrusion drug and coformers are heated with 
intense mixing without addition of solvent, for eg Li  et al, 
synthesized ibuprofen/isonicotinamide cocrystal 
suspensions single-step hot-melt extrusion process47. 
Kevin et al studied synthesis of Carbamazepine Cocrystals 
by Hot-Melt Extrusion author used Carbamazepine  as the 
drug and nicotinamide used as conformer and 
characterized cocrystal matrix by differential scanning 
calorimetry, Fourier transform infrared spectroscopy, 
and powder X-ray diffraction48.  
 
Sonocrystallization Method 49:  
Drug + Coformer 
 
Dissolve together in solvent 
 
Keep for sonication at constant temperature 
 
Formation of cocrystals 
 
Several researchers studied preparation of cocrystals by 
sonocrystallization method Prafulla et al studied 
synthesis of corystals of Caffeine/Maleic Acid by 
Ultrasound-assisted Slurry Co-crystallization. Author 
constructed two phase diagram that is one in the absence 
of and one in the presence of ultrasound, prepared slurry 
by varying quantity of amounts of caffeine, maleic acid, 
and water and other one was subjected to 12 ultrasound 
pulses of 5 s each separated by a gap of 1 s, using a 20-
kHz high-power ultrasound set at 50% amplitude at 
25ºC50.
  
Supercritical fluid atomization technique [Supercritical Antisolvent (SAS) Method]: 
     Drug + Coformer 
 
Dissolve together in high pressurized supercritical fluid 
(CO2) 
 
Automize the solution with automizer at normal temperature and pressure causes conversion of CO2 from liuid state to gas 
state 
 
Formation of co-crystals 
 
Abhijat  et al prepared and characterized Carbamazepine 
and Nicotinamide co-crystals by supercritical fluid process 
(SCF) method and characterized developed cocrystals by 
dissolution studies, differential scanning calorimetry, hot 
stage microscopy, scanning electron microscopy, H NMR 
and X-ray powder diffraction51. Courtney et al studied 
synthesis of Cocrystals of itraconazole and succinic acid by 
gas antisolvent (GAS) cocrystallization using pressurized 
CO2. Author dissolved itraconazole and succinic acid in a 
liquid solvent (tetrahydrofuran) at ambient conditions and 
pressurized solution with CO2, which decreased the 
solvating power of tetrahydrofuran and caused 
crystallization of itraconazole–succinic acid cocrystals. 
Chaqrecterized cocrystals by Powder X-ray diffraction, 
Fourier transform infrared spectroscopy, differential 
scanning calorimetry, and scanning electron microscopy52. 
 
Heating with intense mixing without addition of solvent 
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Spray drying technique:  
Drug + Coformer 
 
Prepare solution or suspension with evaporating solvent 
 
spray solution in hot air steam to evaporate solvent 
 
Formation of cocrystals 
 
Ning et al  synthesized cocrystals of 2,4,6,8,10,12 
hexanitrohexaazaisowurtzitane (CL-20) and 2,4-dinitro-2,4-
diazapentane (DNDAP) in a 2 : 1 molar ratio by a rapid and 
continuous spray drying method spray drying method53. 
Amjad et al synthesized Theophylline Cocrystals by Spray 
Drying technique. Author prepared Cocrystals of 
Theophylline with urea and saccharin with nicotinamide by 
spray drying by using various solvents and solution 
concentrations while dying was done with nitrogen gas54. 
CHARACTERIZATION OF CO-CRYSTALS: 
Characterization of co-crystals includes study of structural 
and physical properties55,56,57,58.  
Following are the techniques for the characterization of 
cocrystals used by different authors for characterization. 
Structural: 
Infrared spectroscopy,  
Single crystal x-ray crystallography and  
powder x-ray diffraction 
 
 
Physical: 55, 56  
Melting point apparatus,  
Differential scanning calorimetry,  
Thermogravimetric analysis 
XD method is generally used for to determine structure of 
cocryatal. XRD study includes single crystal evaluation as 
well as powder XRD. No. of researchers have used this 
technique for characterization of cocrystals. Thermal 
analysis also one of the technique used for the 
characterization of cocrystals. For cocrystal Thermal 
techniques like characterization thermogravimetric 
analysis and differential thermal analysis and differential 
scanning colorimetry are generally used. Spectroscopy 
methods are also used to characterize cocrystals like 
vibrational spectroscopy and nuclear magnetic resonance. 
NMR is a powerful characterization tool that can provide 
detailed information on the structure of organic 
pharmaceutical cocrystals and complexes59,60. Raman 
spectroscopy also one of the tool used for observation of 
crystallization process. It is used to differentiate between 
polymorphs, salts, cocrystals, solid solutions and hydrated 
salts61. Fourier-transform Raman is also used to for the 
identification and quantitative analysis of cocrystals62. 
Zhang et al prepared cocrystals of carbamazepine and 
characterized same with Fourier Transform Infrared 
Spectroscopy (FTIR), Differential Scanning Calorimetry 
(DSC), and Powder X-ray Diffraction (PXRD) techniques63. 
shahram et al synthesized piroxicam cocrystals and 
evaluated them using powder X-ray diffraction, Fourier-
transform infrared spectroscopy, DSC etc64 Desai et al also 
prepared Carbamazepine Cocrystals by Solvent 
Evaporation Technique and evaluated them for Visual 
morphology, differential scanning calorimetry, infrared 
spectroscopy, x-ray diffractometry etc65.crystals of 
piracetam and gentisic acid prepared by slow evaporation 
were characterized by IR, melting point, DSC, PXRD and 
single crystal X-ray diffraction66. 
  
 
Table 1: Reported Methods of Co-Crystals 
Drug Co-former Method used to prepare Ref. 
Piroxicam Adipic Acid, Benzoic Acid, Cinnamic Acid, Citric Acid, Glutaric 
Acid, P-Hydroxybenzoic Acid, Hippuric Acid, 
Malonicacid,Resorcinol, Saccharine Sodium, 1-Hydroxy-2-
Napthoic Acid, Sodium Acetate, Urea, Catechol, Ferulic Acid, 
Aerosil-200, Nicotinamide, Para Amino Benzoic Acid, 
Anthranilic Acid and Succinic Acid 
Dry grinding method. 67 
Darunavir Succinic acid  Cooling crystallization 68 
Aceclofenac Sodium Saccharin Solvent-drop grinding method 69 
Clarithromycin Urea Solvent evaporation 70 
Paracetamol Caffeine Dry grinding, liquid assisted 
grinding (lag), solvent evaporation 
(se), and anti-solvent addition 
71 
Myricetin Proline Solution crystallization based on 
the ternary phase diagram 
principle 
72 
Efavirenz Lactic acid and Adipic acid Solvent evaporation 73 
Fenofibrate Nicotinamide Kneading, solution crystallization, 
antisolvent addition and solvent 
drop grinding methods 
74 
Carbamazepine Glucomannan Solution mediated phase 
transformation 
75 
danazol vanillin Solution crystallization 76 
Felodipine Xylitol  Wet co-grinding  77 
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Fexofenadine Tartaric acid Solvent evaporation 78 
Fenofibrate Nicotinamide Solution cocrystallization 
technique 
79 
Fenofibrate Saccharin, succinic acid, and sucrose  Solution evaporation, slow 
evaporation, antisolvent addition, 
net grinding method, and solvent-
drop grinding methods 
80 
Simvastatin- Nicotinamide Solvent evaporation 81 
Prulifloxacin Salicylic acid Solution crystallization technique 82 
Carbamazepine Succinic acid  Solvent-drop grinding method 83 
Lornoxicam Saccharin, salicylic acid, tartaric acid and pyrogallol Liquid assisted grinding, reaction 
co-crystallization and cooling 
crystallization 
84 
Simvastatin Aspartame Slurry 85 
Mesalamine Glutamine Liquid assisted grinding 86 
Dipfluzine– 
 
Benzoic acid Solvent-assisted co-grinding and 
the solvent ultrasonic methods  
87 
Simvastatin Malic acid Liquid assisted grinding 88 
Gliclazid Succinic acid, Malic acid Liquid assisted grinding 89 
Efavirenz Fumaric acid Neat grinding method 90 
Acyclovir Tartaric acid, succinic acid, malonic acid, glutaric acid, adipic 
acid, citric acid, 4-amino benzamide, 4-hydroxy benzamide, 
4-amino benzoic acid, malic acid, oxalic acid, fumaric acid 
Solvent evaporation, wet grinding, 
and an anti-solvent addition 
91 
Diacerein Urea and tartaric acid Solvent drop grinding method 92 
Hesperetin Picolinic acid, nicotinamide, and caffeine Solvent drop grinding technique 93 
Ketoprofen Cinnamic acid, glutaric acid, maleic acid, malonic acid, 
nicotinamide, oxalic acid, p-amino-benzoic acid, pamino 
salicylic acid, saccharin and urea 
Fusion method 94 
Theophylline Acesulfame, saccharin Solvent drop grinding method 95 
Mefloquine 
hydrochloride 
Benzoic acid  citric acid, oxalic acid, saccharin, salicylic acid, 
succinic acid, pure mefloquine tablets  
Solution cocrystallization method 96 
 
REFERENCES 
1. Babu NJ and Nangia A. Solubility advantage of amorphous drugs 
and pharmaceutical cocrystals. Cryst Growth Des 2011; 11(26): 
62-79. 
2. Fong SYK, Ibisogly A, Bauer-Brandl A. Solubility enhancement of 
BCS class-II drug by solid phospholipid dispersions: Spray 
drying versus freeze-drying. Int J Pharm 2015; 496:382-91.  
3. Jones W, Motherwell WDS, Trask AV. Pharmaceutical co-
crystals: An Emerging approach to physical property 
enhancement. MRS Bull 2006; 31:875-879. 
4. Zaworotko M. Crystal engineering of co-crystals and their 
relevance to pharmaceuticals and solid-state chemistry. Acta 
Cryst 2008; 64:11-12. 
5. Rodríguez-Hornedo N, Nehm SJ, Jayasankar A, Cocrystals: 
design, properties and formation mechanisms, In Encyclopedia 
of Pharmaceutical Technology, 3rd ed, Taylor & Francis, 
London, 2007; 615-635. 
6. Schultheiss N, Newman A. Pharmaceutical co-crystals and their 
physicochemical properties. Cryst Growth Des.2009; 9:2950–
2967. 
7. Tiekink ERT, Vittal JJ (Editors). Frontiers in Crystal Engineering, 
John Wiley & Sons, Ltd, 2006, Chapter 2: Crystal Engineering of 
Pharmaceutical Co-crystals, 25-50. 
8. Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. 
Pharmaceutical co-crystals J Pharm Sci 2006; 95:499-516. 
9. Remenar JF, Morissette SL, Peterson ML, Moulton B, MacPhee 
JM, Guzmán H, Almarsson O, Crystal engineering of novel co-
crystals of a triazole drug with 1,4- dicarboxylic acids. J Am 
ChemSoc 2003; 125(8):456-8457. 
10. Almarsson Ö, Zaworotko MJ. Crystal engineering of the 
composition of pharmaceutical phases. Do pharmaceutical co-
crystals represent a new path to improved medicines? 
ChemCommun 2004; 1889-1896. 
11. Morissette SL, Almarsson O, Peterson ML, Remenar JF, Read MJ, 
Lemmo AV, et al. High-throughput crystallization: polymorphs, 
salts, cocrystals and solvates of pharmaceutical solids. Adv Drug 
Deliv Rev 2004; 56:275-300.  
12. Sekhon BS. Pharmaceutical cocrystals - An update. Chem Inform 
2013; 44:62 
13. Bolla G, Nangia A. Pharmaceutical cocrystals: walking the talk. 
ChemCommun 2016; 42-60.  
14. Shan N, Zaworotko MJ. The role of cocrystals in pharmaceutical 
sciences. Drug Discov Today 2008; 13:440-46.  
15. Abourahma H, Cocuzza DS, Melendez J, Urban JM. Pyrazinamide 
cocrystals and the search for polymorphs. CrystEngComm 
2011; 13:1-22.  
16. Batisai E, Ayamine A, Kilinkissa OEY, Bathori N. Melting point-
solubility-structure correlations in multicomponent crystal 
containing fumaric or adipic acid. Cryst Eng Comm 
2014:16:9992-8.  
17. Zhang H, Zhu Y , Qiao N, Chen Y, Gao L. Preparation and 
Characterization of Carbamazepine Cocrystal in Polymer 
Solution, Pharmaceutics 2017; 9:1-13 
18. Jadhav A, Pore Y. Physiscochemical and micromeretics studies 
on Feofibrate cocrystal, Journal of pharm. Sci. tech. mgmt. 2016; 
2(1) 
19. Panzade P, Shendarkar G, Shaikh S, Rathi P. Pharmaceutical 
Cocrystal of Piroxicam: Design, Formulation and Evaluation. 
Adv Pharm Bull. 2017; 7(3):399-408  
20. Zhouab Z, Lia W et al. Resveratrol cocrystals with enhanced 
solubility and tabletability. International Journal of 
Pharmaceutics. 2016; 509(1–2):391-399 
21. Latif S, Abbas N, Hussain A, Arshad M S, Bukhari N I, Afzal H, 
Riffat S, Ahmad Z, Development of paracetamol-caffeine co-
crystals to improve compressional, formulation and in vivo 
performance, Drug Development and Industrial Pharmacy, 
2018; 44(7):1099-1108. 
22. Mounika P, Vijaya Raj S, Divya1 G. A. Gowramma2 and 
G.Vijayamma3, Preparation and Characterization of Novel Co-
Crystal Forms of Fexofenadine, International Journal of 
Innovative Pharmaceutical Research. 2015; 6(1):458-463. 
23. Sopyan I, Fudholi A, Muchtaridi M, Sari I P, Simvastatin-
nicotinamide co-crystal: design, preparation and preliminary 
characterization, Tropical Journal of Pharmaceutical Research. 
2017; 16 (2):297-303 
24. Chadha R, Saini A, Arora P, Chanda S, Jain D, Cocrystals Of 
Efavirenz With Selected Coformers: Preparation And 
Chaudhary et al                                                                                           Journal of Drug Delivery & Therapeutics. 2018; 8(6-s):350-358   
ISSN: 2250-1177                                                                                 [357]                                                                                  CODEN (USA): JDDTAO 
Characterization, International Journal of Pharmacy and 
Pharmaceutical Sciences, 2012; 4(2).  
25. Bagde SA, Upadhye KP, Dixit GR, Bakhle SS., Formulation and 
Evaluation of Co-Crystals of Poorly Water Soluble Drug, 2017. 
26. Rajurkar VG, Aucharmal AL, Dethe S, Development of Ezogabine 
Co Crystal Formation: An Efficient Approach to Enhance 
Aqueous Solubility, British Biomedical Bulletin, 2015 
27. Muddukrishna Bs, Dengale Sj. Shenoy Gg, Bhat, Preparation, 
Solid State Characterisation Of Paclitaxel And Naringen 
Cocrystals With Improved Solubility, International Journal of 
Applied Pharmaceutics. 2016; 8(4).  
28 Panzade P, Shendarkar G, Shaikh S, Rathi PB, Adv Pharm 
Bull,Pharmaceutical Cocrystal of Piroxicam: Design, 
Formulation and Evaluation 2017; 7(3):399-408 
29. Muddukrishna BS, Aithal K, Pai A, Preparation, Solid State 
Characterization of Etraverine Co-Crystals with Improved 
Solubility for the Treatment of Human Immunodeficiency Virus 
International Journal of Pharmacological and Pharmaceutical 
Sciences. 2017; 11(1).  
30. Gopi SP, Banik M, Desiraju GR. New Cocrystals of 
Hydrochlorothiazide: Optimizing Solubility and Membrane 
Diffusivity Crystal Growth & Design. 2016. 
31. Reddy MN, Anusha P. Development and Characterisation of 
Gliclazide Cocrystals International Journal of Pharmacy and 
Biological Sciences V2018; 8(1):22-32 
32. Rahim SA, Rahman FANasir, ENEM., Ramle NA. Carbamazepine 
Co-crystal Screening with Dicarboxylic Acids Co-Crystal 
Formers International Journal of Chemical and Molecular 
Engineering. 2015; 9(5).  
33. Gadade DD, Pekamwar SS, Lahot SR., Patn SD, Sarode MC. 
Cocrystallization of Etodolac: Prediction of Cocrystallization, 
Synthesis, Solid State Characterization and In Vitro Drug 
Release , Marmara Pharmaceutical Journal, 2017; 21:78-88.  
34. Huang Y, Zhang B, Gao Y, Zhang J, Shi L. Nicotinamide Cocrystal 
with Enhanced Solubility, Dissolution, and Oral Bioavailability. 
2014. 
35. Rajbhar P, Sahu AK., Gautam SS., Prasad RK, Singh V, Nair SK, 
Formulation and Evaluation of Clarithromycin CoCrystals 
Tablets Dosage Forms to Enhance the Bioavailability. The 
Pharma Innovation Journal. 2016; 5(6):05-13 
36. Zhang H, Zhu Y, Qiao  N, Chen Y, Gao L, Preparation and 
Characterization of Carbamazepine Cocrystal in Polymer 
Solution, Pharmaceutics. 2017; 9(54):1-13 
37. Jung S, Choi I, Kim W. Liquid-Assisted Grinding to Prepare a 
Cocrystal of Adefovir Dipivoxil Thermodynamically Less Stable 
than Its Neat Phase. Crystals 2015; 5:583-591 
38. Othman MF, Jamburi N, Anuar N,  Rahim SA, Rohalim NH. 
Ibuprofen-amino acids co-crystal screening via co-grinding 
methods, MATEC Web Conf. 2016; 69  
39. Payghan AS. Preparation and Characterization of Molecular 
Complexes of Fenofibrate Cocrystal. Asian Journal of 
Pharmaceutics. 2017; 11(4). 
40. Setyawan D, Sari R, Yusuf H, Primaharinastiti R. Preparation and 
Characterization of Artesunate - Nicotinamide Cocrystal by 
Solvent Evaporation and Slurry Method. Asian J Pharm Clin Res, 
2014; 7(1):62-65. 
41.  Takata N, Shiraki K,  Takano R, Hayashi Y,  Terada K. Cocrystal 
Screening of Stanolone and Mestanolone Using Slurry 
Crystallization, Cryst. Growth De.2008; 8(8): 3032–3037 
42. Apshingekar PP, Aher S, Kelly AL, Brown EC, Paradkar A. 
Synthesis of Caffeine/Maleic Acid Co-crystal by Ultrasound-
assisted Slurry Co-crystallization, Journal of Pharmaceutical 
Sciences. 2017; 106(1):66-70 
43. Erizal Z, Yeyet Cs, Sundani N S, Auzal H, Hidehiro U, Kotaro F, 
Cocrystalline Phase Transformation of Binary Mixture of 
Trimethoprim and Sulfamethoxazole by Slurry Technique, 
Asian Journal of Pharmaceutical and Clinical Research. 2010; 
3(4).  
44. Momoko N, Shoji K, Hiroshi T, Cocrystal production method 
reducing deposition risk of undesired single component crystals 
in anti-solvent cocrystallization, Journal of Industrial and 
Engineering Chemistry. 2016; 36:40–43 
45.  Chuna N, Wang I, Min-JL, Yun-Tk, Sangkil L, Woo SK, Guang JC, 
Characteristics of indomethacin–saccharin (IMC–SAC) co-
crystals prepared by an anti-solvent crystallization process, 
European Journal of Pharmaceutics and Biopharmaceutics. 
2013; 85(3):854-861 
46. Jeong-WS, Kyu-MH, Sung-HL, Dong-WK. Preparation and 
characterization of adefovir dipivoxil–stearic acid cocrystal 
with enhanced physicochemical properties, Pharmaceutical 
Development and Technology. 2017. 
47. Li S, Yu T, Tian Y, Lagan C, Jones DS, Andrews GP 
Mechanochemical Synthesis of Pharmaceutical Cocrystal 
Suspensions via Hot Melt Extrusion: Enhancing Cocrystal Yield. 
Mol Pharm. 2017. 
48. Kevin B, Andrew O, Rodolfo P, Matrix-Assisted Cocrystallization 
(MAC) Simultaneous Production and Formulation of 
Pharmaceutical Cocrystals by Hot-Melt Extrusion. Journal of 
Pharmaceutical Sciences. 2014; 103(9):2904-2910 
49 Kumar S, Nanda A. Pharmaceutical Cocrystals: An Overview, 
Indian J Pharm Sci 2017; 79(6):858-871 
50. Apshingekar PP, Aher S, Kelly AL, Brown EC, Paradkar A. 
Synthesis of Caffeine/Maleic Acid Co-crystal by Ultrasound-
assisted Slurry Co-crystallization, Journal of Pharmaceutical 
Sciences. 2017; 106(1):66-70 
51.  Shikhar A, Mohan M,  Simerdeep Singh B, Gupta E, Formulation 
development of Carbamazepine–Nicotinamide co-crystals 
complexed with γ-cyclodextrin using supercritical fluid process, 
The Journal of Supercritical Fluids. 2011; 55(3):1070-1078 
52. Courtney A. Ober, Ram B. Gupta, Formation of Itraconazole–
Succinic Acid Cocrystals by Gas Antisolvent Cocrystallization, 
AAPS Pharm Sci Tech. 2012; 13(4):1396–1406. 
53. Ning L, Binghui D, Xianming L, Minghui X, Qian Z, Bozhou W, 
Preparation of CL-20/DNDAP cocrystals by a rapid and continuous 
spray drying method: an alternative to cocrystal formation, 
crystengcomm, 2018. 
54. Amjad A, Waseem K, Graham B, Hardyal G, Ali N, Sitaram P. 
Theophylline Cocrystals Prepared by Spray Drying: 
Physicochemical Properties and Aerosolization Performance, 
AAPS Pharm Sci Tech, 2013; 14(1). 
55. Basavoju S, Bostrom D, Velaga SP. Indomethacin-saccharin co-
crystal: Design, synthesis and preliminary pharmaceutical 
characterization. Pharm Res 2008; 25:530-541.,   
56. Lu J, Rohani S. Preparation and characterization of theophylline 
− nicotinamide cocrystal. Org Process Res Dev, Article ASAP; 
2009. 
57 Zoghbi A., Wang B. Carvedilol solubility enhancement by 
inclusion complexation and solid dispersion: review. Journal of 
Drug Delivery and Therapeutics, 2015; 5(2):1-8.  
58  Wenger M, Bernstein J. An alternate crystal form of gabapentin: 
A cocrystal with oxalic acid. Cryst Growth Des 2008; 8:1595–
1598. 
59. Vogt, FG, Clawson, JS. Strohmeier, M, Edwards, AJ, Solid-State 
NMR Analysis of Organic Cocrystals and Complexes. Cryst. 
Growth Des. 2009; 9:921–937. 
60. Pindelska, E.; Sokal, A.; Kolodziejski, W. Pharmaceutical 
cocrystals, slats and polymorphs: Advanced characterization 
techniques. Adv. Drug Deliv. Rev. 2017; 1:111–146. 
61. Paudel, A, Raijada D, Rantanen J. Raman spectroscopy in 
pharmaceutical product design. Adv. Drug Deliv. Rev. 2015; 89: 
3–20 
62. Langkilde, F.W. Sjoblom, J. Tekenbergs-Hjelte, L. Mrak, J. 
Quantitative FT-Raman analysis of two crystal forms of a 
pharmaceutical compound. J. Pharm. Biomed. Anal. 1997; 
15:687–696 
63. Hao Z, Ying Z, Ning Q, Yang C, Linghuan G, Preparation and 
Characterization of Carbamazepine Cocrystal in Polymer 
Solution, Pharmaceutics. 2017; 9(54):1-13 
64. Shahram E, Khosro A, Mohammad B, Mohammadreza S. 
Piroxicam cocrystals with phenolic coformers: preparation, 
characterization, and dissolution properties Department of  and 
characterized with Pharmaceutical and Food. 2017 
65. Desai H, Rao L, Amin P, Carbamazepine Cocrystals by Solvent 
Evaporation Technique: Formulation and Characterization 
Studies American journal of pharmatech research, 2018 
66. Fleischman SG, Kuduva SS, McMahon JA, Moulton B, Walsh RB, 
Rodriguez-Hornedo N, Zaworotko MJ. Crystal engineering of the 
composition of pharmaceutical phases. 2. Multiple component 
crystalline solids involving carbamazepine. Cryst Growth Des. 
2003; 3:909-919. 
67. Panzade P, Shendarkar G, Shaikh S, Rathi PB, Pharmaceutical 
Cocrystal of Piroxicam: Design, Formulation and Evaluation.  
Advanced Pharmaceutical Bulletin.  2017; 7(3):399-408 
68. Bagde S A, Upadhye K P, Dixit G R, Bakhle S S, Formulation and 
Evaluation of Co-Crystals of Poorly Water Soluble Drug.  
Chaudhary et al                                                                                           Journal of Drug Delivery & Therapeutics. 2018; 8(6-s):350-358   
ISSN: 2250-1177                                                                                 [358]                                                                                  CODEN (USA): JDDTAO 
International Journal of Pharmaceutical Research. 2016; 
7(12):4988-4997. 
69. Saxena M, Kuchekar BS, Cocrystal Formulation, 
Characterization, and Evaluation Study. International 
Conference on Advanced Nanomaterials & Emerging 
Engineering technologies" (ICANMEET-20J3) New Deihl, India. 
2013; 24(26):602-606 
70. Rajbhar P, Sahu A K, Gautam S S, Prasad R K, Singh V, Nair S K, 
Formulation and Evaluation of Clarithromycin Co- Crystals 
Tablets Dosage Forms to Enhance the Bioavailability. The 
Pharma Innovation. 2016; 5(6):5-13 
71. Latif S, Abbas N, Hussain A, Arshad M S, Bukhari N I, Afjal H, 
Development of Paracetamol-Caffeine Cocrystals to Improve 
Compressional, Formulation and In Vivo Performance. 2018; 
44(7):1099-1108 
72. Liu M , Hong C , Yao Y , Shen H, Ji G , Li G , Xie Y.  Development of 
a Pharmaceutical Cocrystal With Solution Crystallization 
Technology: Preparation, Characterization, and Evaluation of 
Myricetin-Proline Cocrystals. European Journal of 
Pharmaceutics and Biopharmaceutics. 2016; 107:151-159 
73. Rajurkar V G, Nagare A M, Ghawate V, Tablet Formulation and 
Enhancement of Aqueous Solubility of Efavirenz by Solvent 
Evaporation Co-Crystal Technique. Med chem, an open access 
journal. 2015 
74. Shewale S, Shete A S, Doijad R C, Kadam S S, Patil V A, Yadav A V, 
Formulation and Solid State Characterization of Nicotinamide-
based Co-crystals of Fenofibrate. Indian Journal of 
Pharmaceutical Sciences. 2015; 77(3):328-334 
75. Hardikar S, Bhosale A, Vanave S, Kamathe B, Preparation and 
Evaluation OF Co-Crystals of Carbamazepine with 
Glucomannan.  International Journal of Pharmacy and 
Pharmaceutical Sciences.2017; 9(10):318-320 
76. Childs S L, Kandi P, Lingireddy S R,Formulation of a Danazol 
Cocrystal with Controlled Supersaturation Plays an Essential 
Role in Improving Bioavailability. 10:3112−3127  
77. Arafa M F, El-Gizawy S A, Osman MA, & Maghraby GM, Xylitol as 
a potential co-crystal co-former for enhancing dissolution rate 
of felodipine: preparation and evaluation of sublingual tablets. 
Pharmaceutical Development and Technology. 2016 
78. Mounika P, Raj1 V S, Divya1 G, Gowramma A, Vijayamma G, 
Preparation and Characterization of Novel Co-Crystal Forms of 
Fexofenadine. International Journal of Innovative 
Pharmaceutical Research.   2015; 6(1):458-463 
79. Shete A S, Khandagale V V, Murthy M, Yadav A V, Sakhre S S, 
Doijad R C, Solid State Characterization and Tableting Studies of 
Ethanol Based Cocrystals of Fenofibrate with Nicotinamide. 
Indian Journal of Pharmaceutical Education and Research. 
2018; 51(2):71-77 
80. Gaikwad E R, Khabade S S, Sutar T B, Payghan S A, Preparation 
and Characterization of Molecular Complexes of Fenofibrate 
Cocrystal. Asian Journal of Pharmaceutics. 2017; 11(4):S745-
S759 
81. Sopyan I, Fudholi A, Muchtaridi M, Puspita Sari I, Simvastatin-
nicotinamide co-crystal: design, preparation and preliminary 
characterization. Tropical Journal of Pharmaceutical Research.  
2017; 16(2):297-303 
82. Tamkhane V V, Design and Development of Prulifloxacin 
Formulations by Co-Crystallization Technique. International 
Journal of Pharma Sciences and Research. 2015; 6(8):1146-
1155 
83. Ullah M,  Ullah H, Murtaza G, Qaisar Mahmood Q, Hussain I, 
Evaluation of Influence of Various Polymers on Dissolution and 
Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in 
Matrix Tablets. BioMed Research International 
84. Patel D M, Shah H R, Patel R J, Patel C,  Preparation and 
Characterization Of Lornoxicam Co-Crystals. World Journal of 
Pharmacy and Pharmaceutical Sciences. 2014; 3(6):713-732 
85.  Kharisma R M, Sopyan I, Dissolution Rate Repairing of 
Simvastatin as A New Approach in Cocrystallization. Der 
Pharmacia Lettre. 2017; 9(6):18-27 
86. Mamatha T, Sama M, Queshi H K, Development and evaluation of 
Mesalamine- Glutamine Cocrystal Tablets for Colon Specific 
Delivery. 2017; 10(5):3866-3874 
87. Lin Y, Yang H, Yang C, Wang J, Preparation, Characterization, and 
Evaluation of Dipfluzine–Benzoic Acid Cocrystals with 
Improved Physicochemical Properties. 2013; 31(3):566-578 
88. Sopyan I, Fudholi A, Muchtaridi M, Puspitasari I, A Novel of 
Cocrystalization to Improve Solubility and Dissolution rate of 
Simvastatin. International Journal of PharmTech Research. 
2016; 9(6):483-491 
89. Chadha R, Rani D, Goyal P, Novel Cocrystals of Gliclazide: 
Characterization and Evaluation. Crystengcomm. 1-19 
90. Gadade DD, Pekamwar SS, Shirsat MD, Crystal Engineering of 
Antiviral Agent Efavirenz for Solubility Enhancement. Journal of 
Drug Delivery and Therapeutics. 2018; 8(1):86-91 
91. Savjani JK, Pathak C, Improvement of Physicochemical 
Parameters of Acyclovir using Cocrystallization Approach.  
Brazilian Journal of Pharmaceutical Sciences. 2016; 52(4):727-
734 
92. Thenge RR, Patond V B, Adhao VS, Ajmire PV, Barde LN, Mahajan 
N M, Tekade N P, Preparation and Characterization of Co-
Crystals of Diacerein. 2017; 28(1):34-41 
93. Chadha K, Karan K, Bhalla Y, Chadha R, Khullar S, Mandal S, 
Vasisht K, Cocrystals of Hesperetin: Structural, 
Pharmacokinetic, and Pharmacodynamic Evaluation. Crystal 
Growth & Design. 2017; 17(5): 2386-2405 
94. Vaghela R, Kulkarni PK, Hani U, Varma VNSK, Raizaday A, 
Enhancing Aqueous Solubility of Ketoprofen by Fusion 
Technique Using Suitable Co-formers. Current Drug Therapy. 
2014; 9(3):199 - 207 
95. Aitipamula S, Wong ABH, Kanaujia P, Evaluating Suspension 
Formulations of Theophylline Cocrystals with Artificial 
Sweeteners. Journal of Pharmaceutical Sciences. 2017;1-30 
96. Shete AS, Yadav AV, Murthy MS, Evaluation of performance of co 
crystals of mefloquine hydrochloride in tablet dosage form. 
Drug Development and Industrial Pharmacy Informa Health 
care. 2013; 39(5):716–723 
 
 
 
 
 
